EFM
E Fund Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Buy |
18,398
+6,079
| +49% | +$198K | 0.03% | 209 |
|
|
2025
Q1 | $465K | Buy |
12,319
+1,840
| +18% | +$69.5K | 0.02% | 235 |
|
|
2024
Q4 | $858K | Buy |
10,479
+6,335
| +153% | +$519K | 0.04% | 165 |
|
|
2024
Q3 | $474K | Sell |
4,144
-1,607
| -28% | -$184K | 0.02% | 202 |
|
|
2024
Q2 | $434K | Sell |
5,751
-211
| -4% | -$15.9K | 0.02% | 189 |
|
|
2024
Q1 | $407K | Sell |
5,962
-2,514
| -30% | -$172K | 0.03% | 214 |
|
|
2023
Q4 | $532K | Buy |
8,476
+60
| +0.7% | +$3.77K | 0.03% | 151 |
|
|
2023
Q3 | $429K | Sell |
8,416
-418
| -5% | -$21.3K | 0.03% | 152 |
|
|
2023
Q2 | $441K | Sell |
8,834
-1,378
| -13% | -$68.8K | 0.03% | 139 |
|
|
2023
Q1 | $383K | Buy |
10,212
+279
| +3% | +$10.5K | 0.03% | 179 |
|
|
2022
Q4 | $476K | Buy |
+9,933
| New | +$476K | 0.04% | 137 |
|